Spots Global Cancer Trial Database for adcetris
Every month we try and update this database with for adcetris cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) | NCT02169505 | Lymphoma | Brentuximab Ved... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) | NCT02096042 | Leukemia | Brentuximab Ved... 5-Azacytidine | 18 Years - | M.D. Anderson Cancer Center | |
Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas | NCT03205891 | Malignant Neopl... Classical Hodgk... Anaplastic Larg... CD30+ Periphera... | Brentuximab Ved... TAK228 Glucose Monitor | 18 Years - | M.D. Anderson Cancer Center |